CARGO Therapeutics Inc. C... (CRGX)
NASDAQ: CRGX
· Real-Time Price · USD
4.54
0.08 (1.79%)
At close: Aug 15, 2025, 3:59 PM
4.54
-0.11%
After-hours: Aug 15, 2025, 04:04 PM EDT
CARGO Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Net Income | -221.78M | -216.19M | -167.5M | -154.14M | -147.71M | -121.21M | -98.15M | -79.82M | -56.63M | -38.78M | -26.03M | -12.29M |
Depreciation & Amortization | 4.95M | 6.44M | 7.07M | 6.81M | 6.07M | 4.86M | 3.69M | 3.02M | 2.33M | 1.48M | 792K | 362K |
Stock-Based Compensation | 21.9M | 20.94M | 17.97M | 14.76M | 10.91M | 7.2M | 3.33M | 1.74M | 679K | 87K | 56K | 24K |
Other Working Capital | -8.74M | 36.3M | 5.7M | 1.14M | 5.95M | 1.4M | 1.99M | 1.95M | 290K | 290K | 290K | -1.86M |
Other Non-Cash Items | 11.97M | 8.39M | -889K | -916K | 5.66M | 7.59M | 11.89M | 13.89M | 7.87M | 7.24M | 5.11M | 2.39M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 30K | 30K | 30K | n/a |
Change in Working Capital | -6.63M | 33.13M | 3.6M | -346K | 7.65M | 4.32M | 2.21M | 1.75M | 1.07M | 202K | 222K | 1.03M |
Operating Cash Flow | -189.59M | -147.29M | -139.74M | -133.84M | -117.43M | -97.25M | -81.16M | -63.53M | -48.79M | -33.89M | -19.83M | -8.48M |
Capital Expenditures | -3.03M | -3.39M | -4.45M | -6.79M | -9.96M | -9.99M | -8.99M | -7.04M | -3.95M | -2.46M | -1.84M | -816K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -330.41M | -398.46M | -609.11M | -493.69M | -360.38M | -292.34M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 472.93M | 422.26M | 304.97M | 160.66M | 73.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 2.82M | 3.32M | 3.51M | 3.51M | -500K | n/a | n/a | -38K | -301K | -301K | -301K | -263K |
Investing Cash Flow | 143.49M | 23.92M | -305.08M | -336.32M | -297.04M | -302.33M | -8.99M | -7.04M | -3.95M | -2.46M | -1.84M | -816K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 3.5M | 15.99M | 19.96M | 19.96M | 16.46M | 3.97M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 224K | 354K | 224K | 292.69M | 291.17M | 291.04M | 291.17M | -506K | 234K | 232K | 232K | 3K |
Financial Cash Flow | 267K | 103.61M | 103.47M | 481.56M | 526.25M | 422.9M | 494.58M | 129.39M | 88.27M | 88.27M | 16.7M | 3.98M |
Net Cash Flow | -45.84M | -19.76M | -341.35M | 11.4M | 111.78M | 23.33M | 404.43M | 58.82M | 35.53M | 51.92M | -4.97M | -5.32M |
Free Cash Flow | -192.62M | -150.68M | -144.19M | -140.63M | -127.39M | -107.24M | -90.16M | -70.57M | -52.74M | -36.35M | -21.67M | -9.29M |